StreetInsider.com News Articles

Form 425 Personalis, Inc. Filed by: Personalis, Inc.

Mon, 20 Jul 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260720/26790556.html

Form 425 Personalis, Inc. Filed by: Personalis, Inc.

Mon, 20 Jul 2026 17:29:00 -0400

si-local-file:///var/storage/secattach/20260720/26790556.html

Form 8-K Personalis, Inc. For: Jul 20

Mon, 20 Jul 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260720/26790538.html

Form 8-K Personalis, Inc. For: Jul 20

Mon, 20 Jul 2026 17:27:00 -0400

si-local-file:///var/storage/secattach/20260720/26790538.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260720/26790519.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:23:00 -0400

si-local-file:///var/storage/secattach/20260720/26790519.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260720/26790512.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:22:00 -0400

si-local-file:///var/storage/secattach/20260720/26790512.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260720/26790496.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:20:00 -0400

si-local-file:///var/storage/secattach/20260720/26790496.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260720/26790469.html

Form 425 Personalis, Inc. Filed by: Tempus AI, Inc.

Mon, 20 Jul 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260720/26790469.html

Personalis (PSNL) PT Raised to $16.25 at BTIG

Mon, 20 Jul 2026 13:15:45 -0400

BTIG analyst Mark Massaro raised the price target on Personalis (NASDAQ: PSNL) to $16.25 (from $11.00) while maintaining a Buy rating.

Needham on Tempus AI Inc (TEM): 'Buyers of any weakness related to the transaction'

Mon, 20 Jul 2026 12:51:26 -0400

Needham analyst Ryan Macdonald reiterated a Buy rating and $75.00 price target on Tempus AI Inc (NASDAQ: TEM).

The analyst comments "We reiterate our Buy rating and $75 price target on Tempus AI (TEM) following company's announcement to acquire Personalis in all stock transaction valued at $1.7B EV ($1.5B net of TEM current ownership), with an option for 50% of the transaction to be funded in cash. While the stock has sold off, we believe the strategic value is misunderstood as Personalis significantly enhances Tempus' offerings in the $20B+ MRD market, which has sub-10% penetration today, while the full force of

Needham on Tempus AI Inc (TEM): 'Buyers of any weakness related to the transaction'

Mon, 20 Jul 2026 12:51:26 -0400

Needham analyst Ryan Macdonald reiterated a Buy rating and $75.00 price target on Tempus AI Inc (NASDAQ: TEM).

PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus

Mon, 20 Jul 2026 11:54:45 -0400

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Julie & Holleman LLP, a nationally recognized shareholder rights firm, is investigating the proposed acquisition of Personalis, Inc. (Nasdaq: PSNL) by Tempus AI, Inc. (Nasdaq: TEM), an existing Personalis shareholder and strategic partner.

For a free consultation, please visit https://julieholleman.com/personalis-inc/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com.

Personalis is a precision oncology company that develops advanced genomic tests designed to detect and monitor cancer. The company has established itself as a leader in molecular residual disease ("MRD")

PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus

Mon, 20 Jul 2026 11:54:45 -0400

For a free consultation, please visit https://julieholleman.com/personalis-inc/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com.

PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus

Mon, 20 Jul 2026 11:54:45 -0400

For a free consultation, please visit https://julieholleman.com/personalis-inc/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com.

PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus

Mon, 20 Jul 2026 11:54:45 -0400

For a free consultation, please visit https://julieholleman.com/personalis-inc/. You may also contact partner Scott Holleman at (929) 415-1020 or by email at scott@julieholleman.com.

Needham Downgrades Personalis (PSNL) to Hold

Mon, 20 Jul 2026 11:34:56 -0400

Needham analyst Mike Matson downgraded Personalis (NASDAQ: PSNL) from Buy to Hold.

The analyst comments "This morning, PSNL announced an agreement to be acquired by Tempus AI (TEM - Buy Rated, covered by Ryan MacDonald) for $16.25 per share of TEM stock or an enterprise value of ~$1.5B. At $16.25 per share, TEM is paying a 2027E EV/sales multiple of 15.5x, well above our small/mid-cap growth comp group, which trades at a median 2027E EV/sales multiple of 3.9x. We believe the premium is warranted given the strong growth in NeXT Personal, multiple Medicare reimbursement wins, and large addressable minimal residual disease

Needham Downgrades Personalis (PSNL) to Hold

Mon, 20 Jul 2026 11:34:56 -0400

Needham analyst Mike Matson downgraded Personalis (NASDAQ: PSNL) from Buy to Hold.

Needham Downgrades Personalis (PSNL) to Hold

Mon, 20 Jul 2026 11:34:56 -0400

Needham analyst Mike Matson downgraded Personalis (NASDAQ: PSNL) from Buy to Hold.

Needham Downgrades Personalis (PSNL) to Hold

Mon, 20 Jul 2026 11:34:56 -0400

Needham analyst Mike Matson downgraded Personalis (NASDAQ: PSNL) from Buy to Hold.

Lake Street Downgrades Personalis (PSNL) to Hold

Mon, 20 Jul 2026 09:52:29 -0400

Lake Street analyst Thomas Flaten downgraded Personalis (NASDAQ: PSNL) from Buy to Hold with a price target of $16.25.

For an analyst ratings summary and ratings history on Personalis click here. For more ratings news on Personalis click here.

Shares of Personalis closed at $15.39 yesterday.

Form 425 Personalis, Inc. Filed by: Personalis, Inc.

Mon, 20 Jul 2026 09:20:00 -0400

si-local-file:///var/storage/secattach/20260720/26787973.html